CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 1,037,017 shares at an average $187.27 ($194,200,043)
- 4 Open-market sale President, COO & GM China sold 0 shares
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale 10% owner sold 17,842,500 shares at $200.00 ($3,568,500,000)
- SC 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 48,351 shares at an average $190.08 ($9,190,570)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- SC 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
Page 17 of 64 · 1,278 filings